Q-omics provides the consensus-scored PRAMEF28P profile across patient tissues and cancer cell-line models. PRAMEF28P expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, PRAMEF28P RNA expression shows 11,462 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight STAD, and TGCT as cancer lineages where PRAMEF28P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.